AI-generated summary
The authors report a case of one 57-year-old man with severe COVID-19 pneumonia who received four daily sessions of photobiomodulation therapy using 808 nm and 905 nm lasers. Oxygen saturation rose, oxygen requirements fell, and several lung and blood indices improved, without ventilator use. The report is a single case without a control group, so the authors state that controlled trials are needed.
- Participants
- 1
- Who or what was studied
- One 57-year-old African American man with severe COVID-19 pneumonia
- Wavelengths
- 808, 905 nm
- Limits stated in the abstract
- Single case report with no control group, and the authors state that controlled clinical trials are required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on amjcaserep.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 905 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Inflammation, Case report, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.